Plain-English translation of NCT06286917 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether noninvasive ventilation — a machine that helps you breathe without requiring surgery — can be safely and successfully started in an outpatient clinic (your local community healthcare setting) instead of only in a hospital ward. The study will compare how well each approach works and look at the costs of both methods for people with ALS who are experiencing breathing difficulties.
Many ALS patients need breathing support as their condition progresses, but starting this treatment typically requires a hospital stay. This trial is exploring whether the treatment could be started more conveniently in an outpatient clinic, potentially making it easier for patients and reducing healthcare costs.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to start your breathing support either at an outpatient clinic near your home or in a hospital pulmonary ward. Researchers will follow your progress to see how well you adapt to the treatment, how you manage with it, and track the costs involved with each approach. The study aims to understand which setting works best for patients like you.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Finland
Tampere University
Enrollment target
~120 participants
Started
March 2024
Primary completion
December 2028
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Heidi A Rantala, MD, PhD
Tampere University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.